Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To clarify the mechanism of stress on the incidence of hyperuricemia
To clarify the differences in intestinal microorganisms and metabolism between healthy people and hyperuricemia patients and across different level of stress
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LSC | healthy people with low level of stress |
| |
| HSC | healthy people with high level of stress |
| |
| LSH | hyperuricemia patients with low level of stress |
| |
| HSH | hyperuricemia patients with high level of stress |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No interventions | Other | No interventions |
|
| Measure | Description | Time Frame |
|---|---|---|
| Phenotype differences in the gut microbiome by metagenomic sequencing. | including microbial composition analysis(Taxonomic Annotation Tools: MetaPhlAn4; Functional Gene Analysis Tools:eggNOG-mapper (functional classification) and diversity metrics(α-diversity (Shannon index) and β-diversity (Bray-Curtis distance, UniFrac distance) | Samples to be collected once per participant within 7 days of enrollment |
| sequencing results of the fecal metabolome in the population | Samples to be collected once per participant within 7 days of enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Serum uric acid | Uric acid in umol/L. | Samples to be collected once per participant within 7 days of enrollment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- 1)Use of any uric acid-lowering drugs, anti-gout drugs, steroids, proton pump inhibitors, or non-steroidal anti-inflammatory drugs within one month before enrollment; 2)Use of any antibiotics, probiotics, or other drugs including traditional Chinese medicine within one month before enrollment; 3)Abnormal liver function, ALT and AST are more than 2.5 times the upper limit of normal; 4)Other diseases that affect glucose and lipid metabolism: hyperthyroidism, hypothyroidism, hypercortisolism, etc.
5)Chronic kidney disease or severe renal impairment, according to eGFR grading <45mL/min/1.73m2; 6)Secondary hyperuricemia 7)Any gastrointestinal diseases
Not provided
Not provided
Hyperuricemia patients and healthy controls
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shanghai Tenth People's hospital | Shanghai | Shanghai Municipality | 200070 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D033461 | Hyperuricemia |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum Sample Collection# and Stool specimen collection